Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Diabetes Research and Clinical Practice|December 17, 2013
Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patientsMilca Asanghanwa, Frans K Gorus, Ilse Weets, et al.
BMC Medicine|May 24, 2023
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetesJean Van Rampelbergh, Peter Achenbach, Richard David Leslie, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 28, 2021
US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?Lorenzo Piemonti, Axel Andres, John Casey, et al.
Drugs in R&D|March 18, 2006
A dual PPAR alpha/gamma agonist increases adiponectin and improves plasma lipid profiles in healthy subjectsKatelijn Decochez, Ronda K Rippley, Jutta L Miller, et al.
Frontiers in Pediatrics|February 22, 2021
Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes MellitusConstance Carels, Lucas Wauters, An Outtier, et al.
The EMBO Journal|March 3, 2006
IA1 is NGN3-dependent and essential for differentiation of the endocrine pancreasGeorg Mellitzer, Stefan Bonné, Reini F Luco, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2008
Interleukin-6 regulates pancreatic alpha-cell mass expansionHelga Ellingsgaard, Jan A Ehses, Eva B Hammar, et al.
Transplantation|August 1, 2019
Heterogeneity of Human Pancreatic Islet Isolation Around Europe: Results of a Survey StudyRita Nano, Julie A Kerr-Conte, Hanne Scholz, et al.
Diabetes Care|February 4, 2025
Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal AnalysisAster K Desouter, Bart Keymeulen, Ursule Van de Velde, et al.
Diabetes|July 16, 2009
Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patientsRobert Hilbrands, Volkert A L Huurman, Pieter Gillard, et al.
Pageof 14